Research on therapeutic clinical trials including immunotherapy in triple-negative breast cancer: a bibliometric analysis.

ABSTRACT:

Background

Breast cancer, particularly triple-negative (TNBC), is a leading malignancy with aggressive traits and high metastasis rates. Clinical trial is an important tool for optimizing therapeutic strategies in the evaluation of the safety and efficacy for TNBC. Our bibliometric study of TNBC clinical trials aims to assess therapeutic strategies, identify trends, and explore advancements in treatment. We focus on mapping knowledge development, including key research entities and topics, and analyzing research trends and emerging methods. This analysis intends to inform future research, especially in personalized and precision medicine for TNBC.

Methods

We selected publications on clinical trials for the treatment of TNBC from 1997 to 2024 in the Web of Science Core Collec

SUBMITTER: Xu Q 

PROVIDER: S-EPMC11513593 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature